Overview

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and the efficacy of Glycopyrrolate as pMDI after single and repeated administration.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.
Treatments:
Glycopyrrolate
Tiotropium Bromide